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RISK OF HOSPITAL-ACQUIRED LEGIONNAIRES’ DISEASE
IN CITIES USING MONOCHLORAMINE VERSUS OTHER
WATER DISINFECTANTS
James D. Heffelfinger, MD, MPH; Jacob L. Kool, MD, PhD; Scott Fridkin, MD; Victoria J. Fraser, MD; Jeffrey Hageman, MHS;
Joseph Carpenter, PE; Cynthia G. Whitney, MD, MPH; Society for Healthcare Epidemiology of America
Approximately 8,000 to 18,000 cases of legionnaires’
disease occur in the United States each year.1 Of these
cases, 80% to 90% are sporadic, whereas 10% to 20% occur
as part of an outbreak.2-4 Thirty-five percent of the cases
reported to the Centers for Disease Control and
Prevention during the period from 1980 to 1998 were
acquired in hospitals, and approximately 30% of these
cases were associated with an outbreak.5 The overall fatal-
ity rate for cases of legionnaires’ disease reported to the
Centers for Disease Control and Prevention was 20% and
the fatality rate for reported cases of hospital-acquired
legionnaires’ disease was 28%.5
Legionnaires’ disease is caused by numerous
species of Legionella, bacteria that are ubiquitous in nat-
ural and man-made aquatic environments.6 Acquisition of
legionnaires’ disease usually occurs following the aspira-
tion or inhalation of aerosols from contaminated potable
water or cooling towers.7-14 Most hospital-acquired out-
breaks of legionnaires’ disease have been associated with
the contamination of hospital drinking water with
Legionella species.15 Efforts to prevent hospital-acquired
legionnaires’ disease have focused on increasing the tem-
perature of hot water and the supplemental chlorination of
drinking water.16-18 Although these measures may be
effective in controlling the growth of Legionella species in
drinking water systems, high water temperatures may
result in scalding injuries and supplemental chlorination
may hasten the development of corrosion and leaks in
plumbing systems.19 The long-term efficacy of alternative
methods for controlling and eradicating legionellae in
hospital water systems (eg, ozone, ultraviolet light, and
copper–silver ionization) has not been determined.
Therefore, guidelines of the Healthcare Infection Control
Practices Advisory Committee recommend performing
surveillance for legionnaires’ disease among patients and
eliminating potential sources if hospital-acquired disease
is suspected.16
Disinfection of municipal drinking water is accom-
plished in two stages. The goal of primary disinfection is
to eradicate microorganisms from raw water entering the
treatment plants and the goal of secondary (residual) dis-
infection is to prevent subsequent new growth of
Drs. Hef felfinger, Kool, and Whitney are from the Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases; and Dr. Fridkin,
Mr. Hageman, and Mr. Carpenter are from the Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease
Control and Prevention, Atlanta, Georgia. Dr. Fraser is from the Division of Infectious Diseases, Department of Medicine, Washington University
Medical Center, St. Louis, Missouri.
Address reprint requests to Cynthia G. Whitney, MD, MPH, Centers for Disease Control and Prevention, 1600 Clifton Road, MS C-02, Atlanta,
GA 30333.
OBJECTIVE: To measure the association between the
disinfection of municipal drinking water with monochloramine
and the occurrence of hospital-acquired legionnaires’ disease
(LD).
SETTING: One hundred sixty-six U.S. hospitals.
DESIGN: Survey of 459 members of the Society for
Healthcare Epidemiology of America (SHEA) for hospital fea-
tures; endemic- and outbreak-related, hospital-acquired LD; the
source of the hospital water supply; and the methods of disinfec-
tion used by the hospitals and municipal water treatment plants.
RESULTS: SHEA members representing 166 (36%) of 459
hospitals responded; 33 (20%) reported one or more episodes of
hospital-acquired LD during the period from 1994 to 1998 and 23
(14%) reported an outbreak of hospital-acquired LD during the
period from 1989 to 1998. Hospitals with an occurrence of hospi-
tal-acquired LD had a higher census (median, 319 vs 221; P =
.03), more acute care beds (median, 500 vs 376; P = .04), and
more intensive care unit beds (median, 42 vs 24; P = .009) than
did other hospitals. They were also more likely to have a trans-
plant service (74% vs 42%; P = .001) and to perform surveillance
for hospital-acquired disease (92% vs 61%; P = .001). After adjust-
ment for the presence of a transplant program and surveillance
for legionnaires’ disease, hospitals supplied with drinking water
disinfected with monochloramine by municipal plants were less
likely to have sporadic cases or outbreaks of hospital-acquired
LD (odds ratio, 0.20; 95% confidence interval, 0.07 to 0.56) than
were other hospitals.
CONCLUSION: Water disinfection with monochlo-
ramine by municipal water treatment plants significantly reduces
the risk of hospital-acquired LD (Infect Control Hosp Epidemiol
2003;24:569-574).
ABSTRACT
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microorganisms in the water distribution systems.
Monochloramine, formed when ammonia and free chlo-
rine are combined in water, has been used as a residual
disinfectant for drinking water since 1916.20,21
Monochloramine is an effective residual disinfectant
because it is more stable than free chlorine,21 allowing
active concentrations to be maintained throughout larger
areas of water system distribution at a decreased cost;
monochloramine also has better penetration into the
biofilm that harbors microorganisms, including
Legionella.22,23 Two previous studies suggest that resid-
ual disinfection with monochloramine by municipal water
treatment plants may have a protective effect against out-
breaks of hospital-acquired legionnaires’ disease.24,25
The aim of this study was to quantify the association
between the residual disinfection of municipal water with
monochloramine and the occurrence of either endemic-
or outbreak-related, hospital-acquired legionnaires’ dis-
ease among a representative sample of hospitals in the
United States.
METHODS
We conducted a retrospective cohort study involv-
ing the hospitals of members of the Society for Healthcare
Epidemiology of America (SHEA). The most senior SHEA
member with infection control responsibilities on record
at each acute care inpatient facility was eligible to be
enrolled.
Standardized questionnaires and requests to par-
ticipate were sent to 459 eligible members in January
1999. Information was requested concerning episodes of
hospital-acquired legionnaires’ disease during the pre-
ceding 5 years (1994 to 1998), outbreaks of hospital-
acquired legionnaires’ disease during the previous 10
years (1989 to 1998), determination of the probable
source of any such infections, hospital demographics, the
nature of surveillance done by the hospital to detect hos-
pital-acquired legionnaires’ disease, the source of the
hospital’s water supply, the type of disinfection used by
the municipal water plant supplying water to the hospital,
and any additional treatment of drinking water per-
formed at the hospital. Following the initial mailing, par-
ticipants were sent two reminders by mail and a third
reminder by either facsimile or e-mail. Surveys with
ambiguous or incomplete information were clarified by
contacting SHEA members, municipal water treatment
plants, or both, by telephone.
Legionnaires’ disease was defined as a clinical diag-
nosis of pneumonia confirmed by chest radiograph in an
individual with at least one of the following: (1) isolation
of Legionella from respiratory secretions or lung tissue;
(2) detection of L. pneumophila serogroup 1 antigen in
urine; (3) detection of Legionella in respiratory secretions
or lung tissue by direct fluorescent antibody; or (4) detec-
tion of a fourfold or greater rise in titers of antibodies
against L. pneumophila in acute- and convalescent-phase
serum, to a value of 1:128 or higher. Definite hospital-
acquired legionnaires’ disease was defined as legion-
naires’ disease occurring in an individual who had been
hospitalized continuously for the entire period of 2 to 10
days before the onset of disease. Probable hospital-
acquired legionnaires’ disease was defined as legion-
naires’ disease occurring in an individual who had been
hospitalized during part of the period from 2 to 10 days
prior to the onset of disease. An outbreak of hospital-
acquired legionnaires’ disease was defined as 2 or more
cases of definite hospital-acquired legionnaires’ disease
occurring in a hospital within a 6-month period. A combi-
nation of either definite cases of hospital-acquired legion-
naires’ disease occurring during the preceding 5 years or
outbreaks of hospital-acquired legionnaires’ disease
occurring during the preceding 10 years was the primary
outcome variable (ie, case-hospitals) used in the analysis.
We used data from the 1997 American Hospital
Association survey to compare the characteristics of hos-
pitals among responders and nonresponders to the sur-
vey regarding hospital census, the number of beds in the
acute and intensive care units, metropolitan size, academ-
ic affiliation, and the presence of oncology and transplant
services.
Statistical testing for differences between the two
groups was performed using the chi-square or Fisher’s
exact test as appropriate. Continuous variables were eval-
uated by the Wilcoxon rank sum test or Student’s t test.
Data were analyzed using Stata software (version 6.0;
Stata Corp., Corpus Christi, TX). We used stepwise multi-
variable logistic regression to assess potential interaction
and confounding by factors known to be associated with
hospital-acquired legionnaires’ disease or those that were
significant at a P value of .1 or less on univariate analysis.
Hospitals reporting only probable hospital-acquired
legionnaires’ disease (n = 10) and those supplied by
municipal water plants that changed the method of resid-
ual disinfection of drinking water from a chlorine-based
system to monochloramine during the study period (n =
4) were excluded from multivariable analyses. No hospi-
tals were supplied by municipal water plants that changed
their method of residual disinfection of drinking water
from monochloramine to a chlorine-based system during
the study period.
Potential confounding factors examined in the mod-
eling process included the number of beds in the inten-
sive care unit, hospital census, water temperature, the
presence of a transplant service (bone marrow, solid
organ, or both), the performance of patient-based surveil-
lance for hospital-acquired legionnaires’ disease (ie, pas-
sive reporting, active laboratory surveillance, or active
surveillance for legionnaires’ disease on hospital wards),
and testing of the drinking water for Legionella species.
Supplemental disinfection of the drinking water by hospi-
tals was not included in logistic regression models
because we did not have information about the timing of
the implementation of supplemental disinfection by hospi-
tals reporting hospital-acquired legionnaires’ disease.
Facilities with hospital-acquired disease that used addi-
tional methods to disinfect their drinking water may have
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implemented these measures in response to cases or out-
breaks of hospital-acquired legionnaires’ disease. Factors
were eliminated on the basis of their significance as con-
founders or effect modifiers and their effect on the preci-
sion of the estimated odds ratio of the main exposure vari-
able. In the final model, associations with a P value of .05
or less were considered statistically significant.
RESULTS
We obtained complete data about hospital-acquired
legionnaires’ disease and municipal water disinfection prac-
tices from 166 (36%) of the 459 eligible SHEA members. We
were able to identify 154 (93%) of the 166 hospitals of the
responding SHEA members and 215 (73%) of the 293 hos-
pitals of the nonresponding SHEA members in the 1997
American Hospital Association data set. Responding hospi-
tals were similar to nonresponding hospitals in average
daily census, metropolitan size, the number of acute care
beds, the number of intensive care unit beds, the presence
of oncology and transplant services, and academic affilia-
tion (Table 1). The 166 respondents were from 40 states
and the District of Columbia (Figure). Forty-one (25%)
reported definite cases during the previous 5 years or out-
breaks of hospital-acquired legionnaires’ disease during
the preceding 10 years, 33 (20%) reported definite cases of
hospital-acquired legionnaires’ disease during the preced-
ing 5 years, and 23 (14%) reported an outbreak of hospital-
acquired disease during the preceding 10 years. Ten (6%)
of the hospitals that reported only probable cases of hospi-
tal-acquired legionnaires’ disease were excluded from fur-
ther analyses. Four additional hospitals (2%) were excluded
from further analyses because they were supplied by
municipal water plants that changed the method of residual
disinfection of drinking water from a chlorine-based system
to monochloramine during the study period. Of the 152
responding hospitals with complete data for exposure and
primary outcome, 38 (25%) reported definite cases in the
previous 5 years or outbreaks of hospital-acquired legion-
naires’ disease in the preceding 10 years, and were thus
considered case-hospitals.
Case-hospitals were larger, had more beds in inten-
sive care units, and were more likely to have transplant
programs, perform patient-based surveillance for legion-
naires’ disease, use additional disinfection methods to
treat their water supply, and maintain hot water at a high-
er temperature than were other hospitals (Table 2).
Hospitals were similar regarding their use of urinary
antigen testing for the diagnosis of legionnaires’ disease.
Residual disinfection methods for drinking water used by
municipal water plants included free chlorine for 89 (59%)
of the hospitals, monochloramine for 58 (38%) of the hos-
pitals, and other methods for 5 (3%) of the hospitals.
Eighteen (47%) of the 38 case-hospitals identified drink-
ing water as the only source of transmission of disease, 2
(5%) of the case-hospitals identified drinking water and
contaminated water in cooling towers as the source of
transmission, 4 (11%) of the case-hospitals identified con-
taminated water in cooling towers or an air conditioning
unit as the sole source of transmission, and 14 (37%) of
the case-hospitals did not identify the source of transmis-
sion.
On multivariable analysis, census, the number of
acute care beds, the number of intensive care unit beds,
TABLE 1
HOSPITAL CHARACTERISTICS OF RESPONDING AND
NONRESPONDING SOCIETY FOR HEALTHCARE EPIDEMIOLOGY OF




Characteristic (n = 154) (n = 215) P
Median average daily 258.5 260 .41
census (range) (20–1,317) (8–1,420)
Median metropolitan 1–2 million 1–2 million .91
size (range) (0–6 million) (0–6 million)
No. with academic 122 (79) 157 (73) .17
affiliation (%)
Median no. of acute 271 236.5 .1
care beds (range)* (0–914) (0–1,169)
Median no. of intensive 34 32 .23
care unit beds (range)* (0–153) (0–160)
No. with a trans- 66 (49) 78 (41) .14
plant service* (%)
No. with an oncology 123 (92) 170 (89) .49
service* (%)
*Information for these variables was available for 134 hospitals of the responding SHEA mem-
bers and 190 hospitals of the nonresponding SHEA members included in the 1997 American
Hospital Association survey.
FIGURE. Distribution of the participating hospitals of members of the
Society for Healthcare Epidemiology of America. Squares represent hospi-
tals reporting hospital-acquired legionnaires’ disease (ie, definite cases or
outbreaks of hospital-acquired legionnaires’ disease; n = 38) and circles
represent hospitals reporting no hospital-acquired legionnaires’ disease
(n = 114). White symbols represent hospitals in municipalities that use
monochloramine as a residual disinfectant and black symbols represent
hospitals in municipalities that do not use monochloramine as a residual
disinfectant.
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and the hot water temperature did not affect the associa-
tion of hospital-acquired legionnaires’ disease with the
method of residual disinfection of the drinking water or
change the risk of hospital-acquired legionnaires’ disease
associated with other factors to an important degree;
these variables were not included in the final multivari-
able model. When adjustment was made for the presence
of a transplant service and patient-based surveillance for
legionnaires’ disease, hospitals supplied by municipal
water plants using monochloramine as a residual disinfec-
tant were less likely to have definite cases or outbreaks of
hospital-acquired legionnaires’ disease than were hospi-
tals supplied with drinking water with another residual
disinfectant (adjusted odds ratio [OR], 0.20; 95% confi-
dence interval [CI95], 0.07 to 0.56) (Table 3). When we
excluded 18 hospitals that did not identify drinking water
as a source of transmission from the analysis, residual dis-
infection with monochloramine was associated with a
greater reduction of the risk of hospital-acquired legion-
naires’ disease (adjusted OR, 0.05; CI95, 0.007 to 0.45).
DISCUSSION
We determined that municipal disinfection of drink-
ing water with monochloramine was associated with a
large reduction in the risk of sporadic cases and out-
breaks of hospital-acquired legionnaires’ disease.
Evidence that residual disinfection of municipal water
with monochloramine may have an impact on hospital-
acquired legionnaires’ disease has been accumulating. In
an outbreak investigation of hospital-acquired legion-
naires’ disease in Texas, investigators did not recover
Legionella species from the hot water systems of 4 par-
ticipating hospitals located in municipalities that used
monochloramine for residual drinking water disinfection,
whereas they found Legionella species in all of the 11 par-
ticipating hospitals located in a municipality using free
chlorine as the residual disinfectant.24 A follow-up study
comparing the municipal water treatment systems at hos-
pitals with reported outbreaks of hospital-acquired
legionnaires’ disease with those from a sample of other
hospitals also demonstrated the protective effect of
monochloramine.25 Laboratory studies support this asso-
ciation as well. An in vitro experiment that measured the
effect of several disinfectants on Legionella growth in a
model water system showed that monochloramine was a
more effective disinfectant than free chlorine at killing
Legionella in biofilm.26 Furthermore, a pilot study of sup-
plemental disinfection of one hospital’s water system
using monochloramine generated on site suggested that
this method might lead to rapid and sustained reduction
of Legionella growth in the hospital’s water system.27
However, our study is the first to assess the effect of the
disinfection of municipal water with monochloramine on
the risk of endemic hospital-acquired legionnaires’ dis-
ease in a representative sample of hospitals in the United
States.
The hospitals that reported hospital-acquired
legionnaires’ disease tended to be larger than those with-
out hospital-acquired disease, in part because immuno-
compromised individuals (eg, patients admitted to trans-
plant or oncology services) are more likely to be treated
at larger hospitals. Also, hospitals reporting legionnaires’
disease were more likely to test their water for Legionella
and to have used supplemental disinfection methods
beyond those used by municipal water plants. We suspect
that testing and supplemental disinfection followed the
identification of hospital-acquired disease at many hospi-
tals. Most hospitals do not implement supplemental disin-
fection unless they identify transmission of hospital-
acquired Legionella or widespread contamination of their
water systems with Legionella.
Limitations of this study include the low rate of
response from SHEA members and the observational
design of the study. Although the response rate was low,
the characteristics of responding hospitals were similar to
those of nonresponding hospitals, and responding hospi-
tals are likely to be representative of the SHEA member-
ship as a whole. Although some hospitals that have had
sporadic cases or outbreaks of hospital-acquired legion-
TABLE 2
COMPARISON OF HOSPITAL CHARACTERISTICS BY STATUS OF
HOSPITAL-ACQUIRED LEGIONNAIRES’ DISEASE* AMONG 152
SURVEYED MEMBERS OF THE SOCIETY FOR HEALTHCARE




Characteristic (n = 38) (n = 114) P
Median census (range) 319 (80–665) 221 (18–999) .03
Median no. of acute 500 376 .04
care beds (range) (120–1,157) (50–1,700)
Median no. of intensive 42 24 .009
care unit beds (range) (6–145) (0–156)
No. with a transplant 28 (74) 48 (42) .001
service† (%)
No. with patient-based 35 (92) 69 (61) .001
surveillance for  
legionnaires’ disease‡ (%)
No. using urine antigen 37 (97) 107 (94) .41
for the diagnosis of 
legionnaires’ disease (%)
No. with supplemental 13 (34) 5 (4) < .001
hospital-based disinfection
of drinking water (%)
Median water temperature, 120 120 .01
°F (range) (100–170) (95–160)
No. with municipal dis- 6 (16) 52 (46) .001
infection of drinking water 
with monochloramine (%)
*Definite cases during 1994 to 1998 or outbreaks during 1989 to 1998.
†Solid organ, bone marrow, or both transplant services.
‡Passive reporting, active laboratory surveillance, or active surveillance on hospital wards for
legionnaires’ disease.
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naires’ disease may have been reluctant to participate in
this study, participation was likely independent of the
method of municipal water disinfection. In addition, our
study likely reflects the experiences of all hospitals in the
United States. In our sample, 20% of the hospitals report-
ed at least one definite case of hospital-acquired legion-
naires’ disease during the previous 5 years and 14%
reported an outbreak of hospital-acquired legionnaires’
disease during the preceding 10 years. This incidence of
disease is comparable to previous estimates.17 However,
any response bias would have led to nondifferential mis-
classification, reducing our power to detect an association
of residual disinfection of drinking water and hospital-
acquired legionnaires’ disease, leading to an underesti-
mation of the protective ef fect of monochloramine.
Because this was an observational study, there may have
been variation in the assessment of the status of hospital-
acquired legionnaires’ disease because of differences in
detecting or reporting cases or outbreaks of disease, and
this may also have resulted in nondifferential misclassifi-
cation and a bias toward the null.
The results of this and previous studies provide fur-
ther evidence that the use of monochloramine for the
residual disinfection of drinking water significantly
reduces the risk of hospital-acquired legionnaires’ dis-
ease. This protective effect may not be restricted to hos-
pitals. Approximately 65% of cases of legionnaires’ disease
in the United States occur outside of hospitals.5 Cooling
towers, hotel water systems, and home water systems are
thought to be the main sources of community-acquired
infection. Widespread use of monochloramine by munici-
pal water treatment plants may reduce the incidence of
community-acquired legionnaires’ disease due to the lat-
ter two sources, and thus it may considerably decrease
the overall incidence of this severe disease. Because free
chlorine reacts with dissolved organic material in water to
produce trihalomethanes and halo-acetic acids, which are
suspected to be carcinogenic,28,29 municipal water depart-
ments have begun to use monochloramine in place of free
chlorine as a residual disinfectant.30 A survey conducted
in 1989 of water utilities serving populations greater than
50,000 found that 23% were using monochloramine as a
residual disinfectant,21 and this proportion likely
increased further in recent years. The protective effect of
residual disinfection with monochloramine should be fur-
ther evaluated in prospective studies. Furthermore, deci-
sions by local municipalities on water treatment practices
should involve local health departments. The infection
control community, as a vital link between local health
departments and hospitals, needs to be aware that munic-
ipal water treatment may have an impact on disease that
occurs within hospitals.
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